 

it"s-tr.

UUID: SFZADOIS- GBES- 4033- BESA- 399921814eC68a
TGC A--DD MW- 01A -PR

llHull||||||I||||||||||||||| I||I||| I|I||||||||| |I||| IIIIICIIenl
| |||I|||IlIII ||II||||I||I|I|||| ||||I||I|II|||||||II||
IIIIIIIIIIIIIIIII lIIlIIIlIIlIllIIIIIIIIIII|||I|IlI|I|IIII

DIAGNOSIS:

Li er, right, posterior sectionectomy:

epatocellular carcinoma, 36

I ) Posbcbemoembolization status: absent
) Size of'tumor; 4x2,8x2.2cm
) Gross type: multinodular confluent type

{I} Satellite nodule: present , ICE) —0- 3
5) Histologic typo: trabccular _ ‘
6) Cell type: classiecell group (I W5 M. 07716;) ‘ - [UQS
v7) Edmondson and Steiner’s histologic grade: ’ ’ (8 i 70/5
The worst differentiation: 4 x . A!” _ I
The major differentiation: 3 < Oxb.’ .' W O Mao

8) Fatty change: absent OZ") 4/351 ”Li

9) Hemorrhage/peIiosis: present (2%)
10) Tumor necrosis: present (5%)
11) Vascular invasion(microscopic)z present
l2) Cap-sole formation: absent 1 I
13) Septal lbrmation: present
I4) Involvement of a major branch of the portal vein: absent
IS) Involvement of a major branch of the hepatic vein: absent
16) Bile duct invasion: present
17) Scrosal invasionzlprcscnt (Glisson's capsule) (Fibrous adhesion)
18) Surgical margin: clear (safety margin: Beta)
19) lntrahepatic metastasis: present
20) Multieentric occurrence: absent
.21) Pathologic stage: AJCCmTZ), (pT4)
22) Related biopsy: none
23) Additional pathologic ﬁndings k

a) Chronic hepatitis, .IiBV~associated

.with minimal tubular activity '
mild porto-pcriportal activity
periportal fibrosis

b). Cirrhosis: absent

c) Dysplasia: absent

(1) Bile duct adenoma. 0.!5mm in size

 

